XML 106 R36.htm IDEA: XBRL DOCUMENT v3.22.4

SHARE-BASED PAYMENTS (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of share-based compensation, stock options, activity

A summary of the Company’s stock option activity is as follows:

			Range of Exercise Prices						Number of Shares						Weighted Average Exercise Price						Weighted Average Remaining Contractual Life (Years)						Intrinsic Value
Outstanding, December 31, 2019			$1.70 - $15.61						1,487,433						$	3.43
Granted			1.76 - 3.06						711,414						1.77
Exercised			1.70 - 2.92						(302,707)						1.97
Forfeited			1.70 - 5.18						(188,541)						3.26
Expired			4.12 - 5.22						(98,512)						4.40
Outstanding, December 31, 2020			$1.70 - $15.61						1,609,087						$	2.91
Granted			3.89 - 8.41						169,310						3.99
Exercised			1.70 - 7.42						(775,814)						2.95
Forfeited			1.76 - 5.91						(8,048)						3.16
Expired			1.70 - 15.61						(51,653)						8.14
Outstanding, December 31, 2021			$1.70 - $8.41						942,882						$	2.79
Granted			5.84 - 10.03						118,318						6.52
Exercised			1.70 - 5.46						(256,315)						2.93
Forfeited			3.06 - 10.03						(20,700)						5.91
Expired			1.76 - 5.18						(16,507)						2.52
Outstanding, December 31, 2022			$1.70 - $8.41						767,678						$	3.24					1.96						$	2,313
Exercisable, December 31, 2022			$1.70 - $8.41						627,097						$	1.52					1.52						$	2,232

Schedule of compensation costs for share-based payment arrangements

The Company's share-based compensation expense, by type of award, is as follows:

			Years Ended December 31,
			2022						2021						2020
Stock options			$	359					$	323					$	555
RSUs(1)			2,244						1,562						1,272
SARs			2,038						273						771
Total recognized expense(2)			$	4,641					$	2,158					$	2,598

(1)The fair value of the RSUs granted under the Compensation Plan for the years ended December 31, 2022, 2021 and 2020 was estimated at the date of grant, using the stated market price on the NYSE American.

(2)Share-based compensation is recorded in Selling, general and administration in the Consolidated Statements of Operations and Comprehensive Income (Loss).

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of the stock options granted under the Compensation Plan is estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:

			Years Ended December 31,
			2022						2021						2020
Risk-free interest rate			2.43		%				0.44		%				1.27		%
Expected life (in years)			3.2 years						5.0 years						4.6 years
Expected volatility(1)			73.21		%				61.96		%				61.81		%
Expected dividend yield			0		%				0		%				0		%
Weighted average grant date fair value			$	4.93					$	2.06					$	0.82

(1)     Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.

Schedule of share-based compensation, restricted stock and restricted stock units activity

A summary of the Company’s non-vested stock option activity is as follows:

			Number of Shares						Weighted Average Grant Date Fair Value
Non-vested, December 31, 2019			223,381						$	1.32
Granted			711,414						0.82
Vested			(508,630)						0.94
Forfeited			(22,175)						0.96
Non-vested, December 31, 2020			403,990						$	0.94
Granted			169,310						2.06
Vested			(351,934)						1.23
Forfeited			(8,049)						1.60
Non-vested, December 31, 2021			213,317						$	1.34
Granted			118,318						4.93
Vested			(170,349)						1.15
Forfeited			(20,700)						4.54
Non-vested, December 31, 2022			140,586						$	4.12

A summary of the Company’s non-vested RSUs activity is as follows:

			Number of Shares						Weighted Average Grant Date Fair Value
Non-vested, December 31, 2019			1,315,536						$	2.45
Granted			740,998						1.65
Vested			(746,477)						2.45
Forfeited			(216,001)						2.13
Non-vested, December 31, 2020			1,094,056						$	1.98
Granted			441,241						3.89
Vested			(635,233)						1.94
Forfeited			—						—
Non-vested, December 31, 2021			900,064						$	2.94
Granted			411,467						6.52
Vested			(518,856)						2.93
Forfeited			(45,250)						5.40
Non-vested, December 31, 2022			747,425						$	4.77

Share-based Payment Arrangement, Stock Appreciation Right, Activity

A summary of the Company’s SARs activity is as follows:

			Number of Shares						Weighted Average Exercise Price						Weighted Average Remaining Contractual Life (Years)						Intrinsic Value
Outstanding, December 31, 2019			2,165,509						$	2.92
Forfeited			(444,886)						2.92
Outstanding, December 31, 2020			1,720,623						$	2.92
Exercised			(48,201)						2.92
Outstanding, December 31, 2021			1,672,422						$	2.92
Granted			833,315						6.47
Exercised			(6,730)						2.92
Forfeited			(46,239)						5.95
Outstanding, December 31, 2022			2,452,768						$	4.07					2.03						$	5,458
Exercisable, December 31, 2022			1,092,143						$	2.92					1.06						$	3,593

A summary of the Company’s non-vested SARs activity is as follows:

			Number of Shares						Weighted Average Grant Date Fair Value
Non-vested December 31, 2019			2,165,509						$	1.25
Granted			—						—
Vested			—						—
Forfeited			(444,886)						1.25
Non-vested December 31, 2020			1,720,623						$	1.25
Granted			—						—
Vested			(1,147,074)						1.27
Forfeited			—						—
Non-vested December 31, 2021			573,549						$	1.19
Granted			833,315						3.99
Vested			—						—
Forfeited			(46,239)						4.13
Non-vested December 31, 2022			1,360,625						$	2.81

Share-Based Payment Arrangement, Restricted Stock Unit, Activity

The fair value of the SARs granted during the year ended December 31, 2022 was estimated at the date of grant using a Monte Carlo simulation, with the following weighted average assumptions:

Risk-free interest rate			1.68		%
Expected life (in years)(1)			4.98 years
Expected volatility(2)			72.81		%
Expected dividend yield			—		%
Weighted average grant date fair value			$	3.99

(1)Monte Carlo analysis of SARs assumes employee suboptimal exercise at first vesting time for each tranche.

(2)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the SARs.

X

- Definition

Schedule of Compensation Costs for Share-based Payment Arrangements [Table Text Block]

+ References

No definition available.

+ Details

Name:	efr_ScheduleOfCompensationCostsForSharebasedPaymentArrangementsTableTextBlock
Namespace Prefix:	efr_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration